Spinifex Pharmaceuticals Pty Ltd.
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Clinical Trials
15
Active:3
Completed:9
Trial Phases
2 Phases
Phase 1:8
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
8 (66.7%)Phase 2
4 (33.3%)Clinical Trial Designed to Determine the Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy
Phase 2
Withdrawn
- Conditions
- Diabetic Neuropathies
- Interventions
- Drug: EMA401 600mgDrug: Placebo
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2015-08-26
- Lead Sponsor
- Spinifex Pharmaceuticals Pty Ltd
- Registration Number
- NCT02435199
Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN
Phase 2
Withdrawn
- Conditions
- Neuralgia, Postherpetic
- Interventions
- Drug: EMA401 200 mgDrug: EMA401 600 mgDrug: Placebo
- First Posted Date
- 2015-04-24
- Last Posted Date
- 2015-08-26
- Lead Sponsor
- Spinifex Pharmaceuticals Pty Ltd
- Registration Number
- NCT02426411
News
No news found